Insiders Oncopeptides AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
2.685 ^SEK	+5.50%		+5.92%	-64.95%

Jul. 02	An undisclosed buyer acquired an 9.166336% stake in Oncopeptides AB (OM:ONCO) from Industrifonden for SEK 22.4 million.	CI
Jun. 27	Oncopeptides AB Selects First Candidate Drug from Its Spike Platform	CI

Oncopeptides' New CFO Takes Office	Nov. 13	MT
Oncopeptides AB Announces the Nomination Committee	23-10-20	CI
Swedish Biotech Oncopeptides Names New CFO	23-08-09	MT
Oncopeptides CEO Leaves; Successor Appointed	23-08-07	MT
Oncopeptides AB Announces Executive Changes	23-08-07	CI
Oncopeptides AB Announces Sofia Heigis to Move from the CCO Role to CEO Role	23-08-07	CI
Oncopeptides CFO to Depart	23-06-14	MT
Oncopeptides' Newly Appointed CFO Assumes Office	23-01-18	MT
Swedish Biotech Oncopeptides Appoints New CFO	23-01-11	MT
Oncopeptides Appoints New CEO	23-01-04	MT
Oncopeptides AB Announces Jakob Lindberg Assumes Chief Scientific Officer	23-01-04	CI
Oncopeptides AB Announces Executive Changes	23-01-04	CI
Oncopeptides AB Announces Nomination Committee Appointments	22-12-22	CI
Idogen Appoints Chief Medical, Chief Regulatory Officers	22-04-13	MT
Oncopeptides Jumps 39% as New CEO Takes Over	21-11-15	MT
Oncopeptides AB Announces Changes in CEO	21-11-15	CI
Oncopeptides AB announces appointment of the Nomination Committee	21-11-12	CI
Oncopeptides Names Interim CFO	21-11-02	MT
Oncopeptides : CFO to Leave	21-10-18	MT
Oncopeptides AB Announces Executive Changes	21-03-08	CI

No results for this search